Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Lehrke

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
Journal of the American College of Cardiology|April 20, 2019
SGLT2 Inhibition: Changing What Fuels the HeartMichael Lehrke
Deutsche Medizinische Wochenschrift (1946)|April 30, 2015
[Prevention of cardiovascular disease in patients with type 2 diabetes]Corinna Lebherz, Michael Lehrke
The Review of Diabetic Studies : RDS|January 21, 2012
Cardiovascular effects of incretin-based therapiesMichael Lehrke, Nikolaus Marx
Herz|July 20, 2022
[Heart and diabetes : What is the importance of GLP-1 receptor agonists in cardiology?]Julia Moellmann, Michael Lehrke
Current Atherosclerosis Reports|August 3, 2014
AAV-mediated gene therapy for atherosclerosisMichael Lehrke, Corinna Lebherz
The American Journal of Cardiology|June 14, 2017
Diabetes Mellitus and Heart FailureMichael Lehrke, Nikolaus Marx
Current Opinion in Lipidology|October 17, 2012
New antidiabetic therapies: innovative strategies for an old problemMichael Lehrke, Nikolaus Marx
Deutsche Medizinische Wochenschrift (1946)|August 20, 2021
[Coronary revascularization: Interventional therapy or coronary bypass surgery]Michael Lehrke, Bernd Niemann
MMW Fortschritte Der Medizin|November 23, 2021
[The cardiovascularly predisposed diabetic patient]Florian Kahles, Michael Lehrke
The American Journal of Medicine|May 21, 2017
Diabetes Mellitus and Heart FailureMichael Lehrke, Nikolaus Marx
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
Journal of the American College of Cardiology|April 20, 2019
SGLT2 Inhibition: Changing What Fuels the HeartMichael Lehrke
Deutsche Medizinische Wochenschrift (1946)|April 30, 2015
[Prevention of cardiovascular disease in patients with type 2 diabetes]Corinna Lebherz, Michael Lehrke
The Review of Diabetic Studies : RDS|January 21, 2012
Cardiovascular effects of incretin-based therapiesMichael Lehrke, Nikolaus Marx
Herz|July 20, 2022
[Heart and diabetes : What is the importance of GLP-1 receptor agonists in cardiology?]Julia Moellmann, Michael Lehrke
Current Atherosclerosis Reports|August 3, 2014
AAV-mediated gene therapy for atherosclerosisMichael Lehrke, Corinna Lebherz
The American Journal of Cardiology|June 14, 2017
Diabetes Mellitus and Heart FailureMichael Lehrke, Nikolaus Marx
Current Opinion in Lipidology|October 17, 2012
New antidiabetic therapies: innovative strategies for an old problemMichael Lehrke, Nikolaus Marx
Deutsche Medizinische Wochenschrift (1946)|August 20, 2021
[Coronary revascularization: Interventional therapy or coronary bypass surgery]Michael Lehrke, Bernd Niemann
MMW Fortschritte Der Medizin|November 23, 2021
[The cardiovascularly predisposed diabetic patient]Florian Kahles, Michael Lehrke
The American Journal of Medicine|May 21, 2017
Diabetes Mellitus and Heart FailureMichael Lehrke, Nikolaus Marx
Pageof 13